Previous Article | Next Article 
Infection and Immunity, September 2005, p. 6147-6150, Vol. 73, No. 9
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.9.6147-6150.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Synthesis of Melanin Pigment by Candida albicans In Vitro and during Infection
Rachael Morris-Jones,1*
Beatriz L. Gomez,1
Soraya Diez,1
Martha Uran,2
Stephen D. Morris-Jones,3
Arturo Casadevall,4
Joshua D. Nosanchuk,5 and
Andrew J. Hamilton1
Dermatology Department, St. John's Institute of Dermatology, Guy's Hospital, Guy's, Kings, and St. Thomas' Medical Schools, London, United Kingdom,1
Corporación para Investigaciones Biológicas, Medellin, Colombia,2
Department of Microbiology,University College Hospital, London, United Kingdom,3
Department of Microbiology & Immunology,4
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York5
Received 7 February 2005/
Returned for modification 15 March 2005/
Accepted 4 May 2005

ABSTRACT
Melanins are implicated in the pathogenesis of several important
human diseases. This study confirmed the presence of melanin
particles in
Candida albicans in vitro and during infection.
Dark particles were isolated from the digestion of
C. albicans cultures and from infected tissue, as established by electron
microscopy and immunofluorescence techniques.

TEXT
The polymorphic fungus
Candida albicans is the causative agent
of candidiasis, which is the most commonly encountered human
fungal disease (
3). Despite its global importance, there is
limited information relating to the factors that play a role
in the pathogenesis of candidiasis; however, there is mounting
evidence to suggest that virulence in this organism is multifactorial
(
11). Melanins make up a heterogeneous class of natural pigments
that have a myriad of biological functions (
7). Melanization
has gained increasing importance as a putative virulence factor
in several fungal pathogens and may therefore be a virulence
trait conserved across many fungal species (
7). In this study,
we aimed to determine whether
C. albicans could synthesize melanin
in yeast cells, utilizing techniques developed to study and
isolate melanin from other fungal pathogens.
C. albicans strains
used were as follows: F28370, F14985, W90572, W91405, T31119,
F10646, and M9958 (University College Hospital, London, United
Kingdom); 3179 (National Collection of Pathogenic Fungi [NCPF],
Bristol, United Kingdom); and CIB 1276 and ATCC 24433 (Corporación
para Investigaciones Biológicas [CIB], Medellin, Colombia).
Cryptococcus neoformans JEC21 (Mel
+) and its albino mutant HMC6
(Mel
) were used as positive and negative controls. Melanin
particles were isolated from yeast cells of all strains of
C. albicans and from infected murine kidney and human skin tissue,
as previously described (
4), by sequential digestion steps and
boiling in hot concentrated acid. The resultant particles were
a quarter of the size of the yeast cells, as demonstrated by
scanning electron microscopy (Fig.
1A and B). No particles were
isolated from the
C. neoformans albino mutant. Transmission
electron microscopy of the melanin particles from
C. albicans revealed small thin layers of electron-dense material surrounding
a void (Fig.
1C and D). Electron spin resonance spectroscopy
of the dark particles isolated was performed at Albert Einstein
College of Medicine, Bronx, N.Y., by documented methodology
(
8,
13). The spectra were identical to the signals generated
from
C. neoformans-derived melanin (reference
14 and data not
shown).
Enzyme-linked immunosorbent assay plates coated with melanin
(from
C. albicans,
Sporothrix schenckii, and
C. neoformans)
were prepared as previously described (
6) and incubated with
anti-melanin monoclonal antibodies (MAbs) 8B5 generated against
S. schenckii yeast melanin (
6), 6D2 generated against melanin
from
C. neoformans (
10), and 8F5 generated against melanin from
Aspergillus fumigatus (
15). Negative controls included wells
with no melanin and peroxidase-conjugated goat anti-mouse (GAM)
alone. The anti-melanin MAbs reacted against the melanin particles
derived from
C. albicans (Fig.
2), and the reactivities were
equal in intensity to those observed with melanin particles
from the positive controls.
C. albicans 3179 yeast cells were embedded in optimal cutting
temperature compound (BDH), and the frozen blocks were sectioned
(cryostat Figocut 2700) and stored at 20°C. Fungal
sections were fixed in cold acetone and air dried. Slides were
blocked with Superblock (Roche, Sussex, United Kingdom) overnight
at 4°C and incubated for 2 h at 37°C either with 10
µg of MAb 8B5, 8F5, or 6D2 with a 1:100 dilution of fluorescein
isothyiocyanate (FITC) GAM immunoglobulin M (IgM) for 2 h at
37°C. Negative controls consisted of 5C11 with FITC-labeled
antibody or FITC-labeled antibody alone. Microscopy showed anti-melanin
MAb bound to small structures within the cryosectioned
C. albicans yeast cells (Fig.
3A to C). Uncut yeast did not bind to the
anti-melanin MAbs. Melanin extracted from
C. albicans yeast
was also reactive; these particles typically formed aggregates
(Fig.
3D and E). Melanin particles were unreactive with the
negative control, MAb 5C11.
Immunocompetent mice were immunized with
C. albicans F28370.
The infection protocol was a modified version of that previously
described (
2). At the CIB in Colombia, isogeneic 6-week-old
male BALB/c mice were immunized intravenously via the lateral
tail vein with 100 µl of
C. albicans (4
x 10
6 CFU/mouse)
in sterile phosphate-buffered saline and sacrificed at 21 days.
Target organs (heart, lungs, liver, spleen, and kidneys) were
fixed and embedded in paraffin, and sera were stored at 70°C.
Paraffin-embedded human skin samples from patients infected
with cutaneous
C. albicans (a gift from A. Restrepo, CIB) were
also used. Tissue was sectioned and stained with periodic acid-Schiff
stain and methenamine silver (Grocott modification); blocks
positive for fungi were processed for immunohistochemical staining
with MAbs, as previously described (
6). Briefly, tissue was
incubated with melanin-binding MAbs at a dilution of 1:100 at
37°C and then with 1:100 FITC-conjugated GAM IgM. Negative
controls were described above.
C. albicans melanin particles
were isolated from the tissues and from cultures and air dried
onto 3-aminopropyltriethoxysilane slides. Tissues were then
probed with anti-melanin MAbs and FITC GAM IgM, as described
above.
C. albicans yeast and hyphae were seen in significant
numbers in the kidneys alone. Reactivity with anti-melanin MAb
8B5 was observed as small fluorescent particles within yeast
cells (Fig.
3F and G) but not in the hyphal forms. Digestion
of infected murine kidneys resulted in isolation of melanin
particles, which reacted with anti-melanin MAb (Fig.
3H and I).
Sera (diluted 1:100) from
C. albicans-infected mice showed
positive recognition of the melanin from cultures and tissue
compared to normal mice sera (data not shown). Melanin particles
were also isolated from infected human skin tissue and reacted
with the anti-melanin MAbs (data not shown).
Laccase enzymes are utilized in the synthesis of melanin; hence, their activity was anticipated in C. albicans cytoplasmic yeast extracts (CYEs). These were harvested as previously described (13), and protease inhibitor cocktail was added (Sigma). The suspension was frozen using liquid nitrogen and smashed until >90% of the cells were broken. The CYE was concentrated using Amicon tubes (molecular mass cutoff, 1 kDa), and the protein content was determined by Coomassie blue methodology. Commercially prepared laccase (Rhus vernificera) (Sigma) and CYEs from C. albicans strains were separated by 10% polyacrylamide gel electrophoresis (30 mA overnight) under nondenaturing conditions. Duplicate samples were loaded onto the gels, one of which had been boiled for 5 min. Gels were incubated with 1 mM L-3,4-dihydroxyphenylalanine (L-DOPA) buffer overnight. Positive laccase activity was revealed by C. albicans CYEs, as shown by dark bands (Fig. 4), which confirmed L-DOPA had polymerized to form melanin. Boiling of the samples prior to loading into the gel eliminated the laccase activity.
This study provides the first definitive evidence that melanization
occurs in
C. albicans and may represent a new virulence factor.
The biosynthesis of melanin in most fungal pathogens leads to
the accumulation of pigment beneath the cell wall, resulting
in so-called melanin ghosts which retain the shape and size
of the original propagules (
9). However, the small spheres of
melanin derived from
C. albicans are more akin to the sclerotic
bodies (comparable to melanosomes) found in
Fonsecaea pedrosoi,
which causes chromoblastomycosis (
1).
C. albicans yeast cells
secrete complex polymers into biofilm structures (
5) whose composition
is not fully understood; one hypothesis therefore might be that
melanin particles are secreted into these resistant extracellular
structures. Melanization may be an attractive target for novel
antimicrobial drugs; therefore, the investigation of melanin-inhibiting
compounds should be pursued in the future. The genome of
C. albicans has recently been unraveled (
12), so evidence from
genetic studies is likely to shed further light on these findings.

ACKNOWLEDGMENTS
We thank the Wellcome Trust (United Kingdom) for supporting
R.M.-J. J.D.N. and A.C. are supported by National Institutes
of Health grant NIH AI52733
We thank A. Restrepo (Corporación para Investigaciones Biológicas, Medellin, Colombia) for supplying human skin tissue infected with candidiasis and Luz Elena Cano for supplying tissue from murine candidiasis infection models. We thank A. Robson and G. Orchard (St John's Institute of Dermatology, London, United Kingdom) for dermatopathological support, and P. Aisen (Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, N.Y.) for help with TEM and SEM studies.

FOOTNOTES
* Corresponding author. Mailing address: St. John's Institute of Dermatology, St. Thomas' Hospital, London SE1 9RT, United Kingdom. Phone: 02079554663. Fax: 011 44 2079552103. E-mail:
themojos{at}boltblue.com.

Editor: T. R. Kozel

REFERENCES
1 - Alviano, C. S., S. R. Farbiarz, W. D. De Souza, J. Angluster, and L. R. Travassos. 1991. Characterization of Fonsecaea pedrosoi melanin. J. Gen. Microbiol. 137:837-844.[Abstract/Free Full Text]
2 - Brieland, J., D. Essig, C. Jackson, D. Frank, D. Loebenberg, F. Menzel, B. Arnold, B. DiDomenico, and R. Hare. 2001. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect. Immun. 69:5046-5055.[Abstract/Free Full Text]
3 - Cutler, J. E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45:187-218.[CrossRef][Medline]
4 - Gomez, B. L., J. D. Nosanchuk, S. Diez, S. Youngchim, P. Aisen, L. E. Cano, A. Restrepo, A. Casadevall, and A. J. Hamilton. 2001. Detection of melanin like pigments in the dimorphic fungal pathogen Paracoccidioides brasiliensis in vitro and during infection. Infect. Immun. 69:5760-5767.[Abstract/Free Full Text]
5 - Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.[Abstract/Free Full Text]
6 - Morris-Jones, R., S. Youngchim, B. L. Gomez, P. Aisen, R. J. Hay, J. D. Nosanchuk, A. Casadevall, and A. J. Hamilton. 2003. Synthesis of melanin-like pigments by Sporothrix schenckii in vitro and during mammalian infection. Infect. Immun. 71:4026-4033.[Abstract/Free Full Text]
7 - Nosanchuk, J. D., and A. Casadevall. 2003. The contribution of melanin to microbial pathogenesis. Cell. Microbiol. 5:203-223.[CrossRef][Medline]
8 - Nosanchuk, J. D., J. Rudolph, A. L. Rosas, and A. Casadevall. 1999. Evidence that Cryptococcus neoformans is melanized in pigeon excreta: implications for pathogenesis. Infect. Immun. 67:5477-5479.[Abstract/Free Full Text]
9 - Rosas, A. L., J. D. Nosanchuk, B. L. Gomez, W. A. Henson, and A. Casadevall. 2000. Isolation and serological analyses of fungal melanins. J. Immunol. Methods 244:69-80.[CrossRef][Medline]
10 - Rosas, A. L., J. D. Nosanchuk, M. Feldmesser, G. M. Cox, H. C. McDade, and A. Casadevall. 2000. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect. Immun. 68:2845-2853.[Abstract/Free Full Text]
11 - Ruechal, R. 1990. Virulence of Candida species, p. 47-65. In L. P. Samaranayake and T. W. MacFarlane (ed.), Oral candidosis. Wright, London, United Kingdom.
12 - Tait, E., M. C. Simon, S. King, A. J. Brown, N. A. R. Gow, and D. J. Shaw. 1997. A Candida albicans genome project: cosmid contigs, physical mapping, and gene isolation. Fungal Genet. Biol. 21:308-314.[CrossRef][Medline]
13 - Wang, Y., P. Aisen, and A. Casadevall. 1995. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect. Immun. 63:3131-3136.[Abstract]
14 - Wang, Y., P. Aisen, and A. Casadevall. 1996. Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans. Infect. Immun. 64:2420-2424.[Abstract]
15 - Youngchim, S., R. Morris-Jones, R. J. Hay, and A. J. Hamilton. 2004. Production of melanin by Aspergillus fumigatus. J. Med. Microbiol. 53:175-181.[Abstract/Free Full Text]
Infection and Immunity, September 2005, p. 6147-6150, Vol. 73, No. 9
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.9.6147-6150.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Erb-Downward, J. R., Noverr, M. C.
(2007). Characterization of Prostaglandin E2 Production by Candida albicans. Infect. Immun.
75: 3498-3505
[Abstract]
[Full Text]
-
Frases, S., Chaskes, S., Dadachova, E., Casadevall, A.
(2006). Induction by Klebsiella aerogenes of a Melanin-Like Pigment in Cryptococcus neoformans. Appl. Environ. Microbiol.
72: 1542-1550
[Abstract]
[Full Text]